Dexcel Pharma is a leading manufacturer in the Israeli market, supplying approximately 20% of all prescription drugs consumed in the country. Our portfolio includes Generics, OTC, Biosimilars, and innovative Branded Rx drugs promoted under exclusive licensing agreements
Dexcel Pharma is a leading manufacturer in the Israeli market, supplying approximately 1 out of 5 of all prescribed drugs in the country. Our portfolio includes Generics, OTC, Biosimilars, and innovative Rx drugs promoted under exclusive licensing agreements
We are proud to collaborate and build long-lasting partnerships with prominent biopharmaceutical companies
We have commercial expertise across primary-care and specialty-setting therapeutic areas including
Our in-house experience allows us to finalize professional legal agreements in a short period of time
Ability to lead new drug launch process from pre-commercial activities, KOL acceptance, market adoption and post-launch and product support
Our experienced regulatory team allows us to file and register a range of pharmaceutical products, in alignment with local regulations
We have complete coverage of healthcare professionals, covering all pharmacies across the country
We have complete coverage of healthcare professionals, covering all pharmacies across the country
We have expertise in creating leading pharma brands while developing product positioning for a specific target audience
